Upon validation of this integrated platform encompassing tumour-stroma interactions pathological avenues in tumour tissue will be delineated to form the foundation for a greater understanding of proteolytic activities of specific proteases involved in ovarian cancer progression and to design more efficient therapies.
展开▼